FDA Inspection
AX Pharmaceutical CorporationAX Pharmaceutical Corporation – FDA Inspection, Sep 1, 2017
Record Details
This FDA Inspection record concerns AX Pharmaceutical Corporation, with an inspection on September 1, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9bed0c81-dd35-4ab2-a259-a81c2471bf81
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1027810
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of AX Pharmaceutical Corporation
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2024 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| May 6, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 20, 2016 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for AX Pharmaceutical Corporation
- FDA Inspection 1236258 - 2024-03-05
- FDA Inspection 1169095 - 2022-05-06
- FDA Inspection 973398 - 2016-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.